TROY EDWARD WILSON - President and CEO, Director at Kura Oncology, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: President and CEO, Director
Issuer Symbol: KURA on Nasdaq
All Insider Reports: All Insider Reports

TROY EDWARD WILSON - trading volume in the past year for Kura Oncology, Inc.

	Shares	%	Avg Price	Total $
Buys	+100,000	73%	$7.13	+$713,346
Sells	-36,615	27%	$8.94	-$327,419
Net	+63,385	46%		+$385,928

Holdings reported by TROY EDWARD WILSON for Kura Oncology, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	429,353	$2,207,408	$8.94	13 Nov 2025	Direct
Common Stock	300,000	$1,806,000	$6.02	13 Nov 2025	by Lorax Charitable Remainder Unitrust
Common Stock	279,194	$1,680,747	$6.02	13 Nov 2025	by One Fish Two Fish Revocable Trust
Option to purchase common stock	1,120,000			02 Jan 2026	Direct	Common Stock

Transactions reported by TROY EDWARD WILSON for Kura Oncology, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.